This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
antibody
product name :
MOUSE ANTI PSMC3
catalog :
VMA00739
quantity :
100 µl
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
OTI1C10
reactivity :
human
application :
western blot
product information
Entity Category :
Antibodies
Product Code :
VMA00739
Description :
MOUSE ANTI PSMC3
Specificity :
PSMC3
Target Species :
Human
Host :
Mouse
Format :
Purified
Isotypes :
IgG2a
Applications :
WB
Application Types :
Western Blotting
Cross Reactivities :
Rat
Clone :
OTI1C10
Quantity :
100 µl
Quantity Value :
100 µl
Quantity Type :
ul
GO Accessions :
GO:0000082, GO:0000084, GO:0005515, GO:0000216, GO:0000502, GO:0003713, GO:0003714, GO:0017111, GO:0006915, GO:0005524, GO:0005634, GO:0005737, GO:0006521, GO:0006977, GO:0016032, GO:0016071, GO:0042981, GO:0031145, GO:0044419, GO:0051436, GO:0051437
GO Terms :
26S proteasome, activation of ubiquitin ligase activity during mitotic cell cycle, alpha-2 macroglobulin receptor-associated protein activity, anaphase promoting complex inhibition during mitotic cell cycle, anaphase-promoting complex inhibition during mitotic cell cycle, anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein breakdown, anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolism, anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein degradation, APC inhibition during mitotic cell cycle, APC-dependent proteasomal ubiquitin-dependent protein catabolic process, APC-dependent proteasomal ubiquitin-dependent protein catabolism, apoptosis regulator activity, apoptotic cell death, apoptotic program, apoptotic programmed cell death, apyrase activity, cell nucleus, down regulation of ubiquitin ligase activity during mitotic cell cycle, downregulation of ubiquitin ligase activity during mitotic cell cycle, down-regulation of ubiquitin ligase activity during mitotic cell cycle, GO:0008632, GO:0045308, inhibition of ubiquitin ligase activity during mitotic cell cycle, interaction with another species, interspecies interaction, interspecies interaction with other organisms, mitotic anaphase promoting complex inhibition, mitotic anaphase promoting complex inhibitor, mitotic anaphase-promoting complex inhibition, mitotic anaphase-promoting complex inhibitor, mitotic APC inhibition, mitotic APC inhibitor, mitotic SCF complex activator, mitotic SCF complex inhibitor, mitotic ubiquitin ligase activator, mitotic ubiquitin ligase inhibitor, mRNA metabolism, negative regulation of ubiquitin ligase activity during mitotic cell cycle, negative regulation of ubiquitin-protein ligase activity during mitotic cell cycle, NTPase activity, nucleoside 5-triphosphatase activity, nucleoside triphosphatase activity, nucleoside triphosphate hydrolase activity, nucleoside triphosphate phosphohydrolase activity, nucleoside-5-triphosphate phosphohydrolase activity, positive regulation of cell cycle arrest by p53-mediated DNA damage response, positive regulation of ubiquitin ligase activity during mitotic cell cycle, positive regulation of ubiquitin-protein ligase activity during mitotic cell cycle, programmed cell death by apoptosis, protein amino acid binding, protein degradation tagging activity, protein folding chaperone, protein tagging activity, regulation of amino acid metabolism, signaling (initiator) caspase activity, S-phase of mitotic cell cycle, stimulation of ubiquitin ligase activity during mitotic cell cycle, transcription co-activator activity, transcription co-repressor activity, type I programmed cell death, unspecific diphosphate phosphohydrolase activity, up regulation of ubiquitin ligase activity during mitotic cell cycle, upregulation of ubiquitin ligase activity during mitotic cell cycle, up-regulation of ubiquitin ligase activity during mitotic cell cycle, viral infection, viral life cycle, viral replication cycle, virulence
Uniprot Accessions :
P17980
Gene :
PSMC3
GeneID URL :
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=5702
EntityFormats :
Purified
UNSPSC :
41116161
Product Form :
Purified IgG - Liquid
PrimarySecondary :
Primary
company information

Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.
questions and comments